Media

Haoxi Health Tech

Meituan

Conference Minutes

03690

SHEN

HMTD

83690

MPNGY

09988

89988

BABA

KBAB

BABO

BABX

01810

81810

XIACY

HBBD

HXXD

The following are the Minutes of the FY25 Q3 earnings call for $MEITUAN(03690.HK) organized by Dolphin Research. For an interpretation of the financial report, please refer to &#34;Meituan: A Loss of Nearly 20 Billion! Did Alibaba Really Succeed in Stealing the House This Time?&#34; 1. Review of Core Financial Data Performance Overview: Total Revenue: 95.5 billion yuan (YoY +2%). Profitability: Operating cost rate 73.6% (YoY +12.9pts), mainly due to rider incentives and rising overseas costs; adjusted net loss of 16 billion yuan, affected by irrational industry competition and strategic investments...

MEITUAN

SHENANDOAH TELE

Meituan HK SDR 5to1

Ps India Port

First Trust Global Wind Energy

MEITUAN-WR

BABA-W

BABA-WR

Alibaba

KraneShares 2x Long BABA Daily ETF

YieldMax BABA Option Income Strategy ETF

BABA 2x Long Daily ETF - GraniteShares

XIAOMI-W

XIAOMI-WR

Xiaomi Corporation

Alibaba HK SDR 5to1

Xiaomi HK SDR 2to1

Meituan (Minutes): 3Q loss peaks, but 4Q will continue the loss trend

Haoxi Health Tech released FY2026 Semi-Annual earnings on April 22 (EST), actual revenue USD 33.83 M, actual EPS USD -1.5333

Haoxi Health Tech released FY2026 Q1 earnings on April 22, 2026 (EST), with actual revenue of USD 16.91 M and EPS of USD -0.7666

Haoxi Health Tech released FY2026 Q2 earnings on April 22 (EST), actual revenue USD 16.91 M, actual EPS USD -0.7666

Haosai Health Technology and Eaglepoint AI Enter Three-Year Partnership to Develop AI Health Management Platform

Haoxi Health Tech released FY2025 Q4 earnings on October 20 EST, with actual revenue of USD 4.425 M and EPS of USD 0.571

Haoxi Health Tech released FY2025 Annual Earnings on October 20 (EST), actual revenue USD 32.8 M, actual EPS USD 1.3224

Haoxi Health Tech released FY2025 9 Months Earnings on October 20, 2025 (EST), Actual Revenue: USD 28.38 M, Actual EPS: USD -2.6322

Haoxi Health Tech released FY2025 Q3 earnings on October 20 (EST), actual revenue USD 4.425 M, actual EPS USD 0.571

Haoxi Health Tech released FY2025 Semi-Annual Earnings on April 23 (EST), actual revenue USD 23.95 M, actual EPS USD -3.2032

Haoxi Health Tech released FY2025 Q2 earnings on April 23 (EST), actual revenue USD 11.98 M, actual EPS USD -1.6016

Haoxi Health Tech released FY2025 Q1 earnings on April 23 (EST), actual revenue USD 11.98 M, actual EPS USD -1.6016

Haoxi Health Tech released FY2024 annual earnings on October 29 (EST), with actual revenue of 48.52 M USD and actual EPS of 1.0552 USD

Haoxi Health Tech released FY2024 Q4 earnings on October 29 (EST), actual revenue USD 12.51 M, actual EPS USD 0.2094

Haoxi Health Tech released FY2024 Q3 earnings on October 29 (EST), actual revenue USD 12.51 M, actual EPS USD 0.2094

Haoxi Health Tech released FY2024 9 Months Earnings on October 29 (EST), with actual revenue of USD 36.01 M and EPS of USD 0.8541

Haoxi Health Tech released FY2024 Semi-Annual Earnings on May 31 (EST), actual revenue USD 23.5 M, actual EPS USD 0.6446

Haoxi Health Tech released FY2024 Q2 earnings on May 31 (EST) with actual revenue of USD 11.75 M and EPS of USD 0.3223

Haoxi Health Tech released FY2024 Q1 earnings on May 31 (EST), actual revenue USD 11.75 M, actual EPS USD 0.3223

Haoxi Health Tech released FY2023 9 Months Earnings on October 24 (EST), with actual revenue of 18.7 M USD and EPS of 0.6552 USD

Haoxi Health Tech released FY2023 earnings on October 24, 2023 (EST) with actual revenue of USD 28.23 M and EPS of USD 0.87

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

Reverse Stock Split

合股

Ex Date: 2026.05.21 (EST), 1-for-128 Reverse Stock Split

Haoxi Health Technology Ltd (HAO) is implementing a 1-for-128 reverse share split to boost its stock price and comply with Nasdaq requirements. The new par value will be $0.32 per share, effective May 21, 2026. The number of outstanding shares will decrease significantly, from over 235 million to approximately 1.8 million Class A shares. HAO shares recently traded at $0.0134, down 24.72% before the split.

nasdaq

Nasdaq

Haoxi Health Announces 1-for-128 Reverse Share Split; Stock Plunges

Haoxi Health Technology Ltd (HAO) shares surged over 20% in pre-market trading, driven by renewed investor enthusiasm. This follows a $6.5 million registered direct offering announced by Univest Securities, LLC, with proceeds aimed at working capital. Despite a recent drop to a 52-week low of $0.016, HAO is now trading at $0.02 in pre-market. The company attributes its growth to the rise of newsfeed ads and the healthcare sector's rapid development.

Univest Financial

Haoxi Health Technology Jumps Over 20%; What's The Buzz?

MEHA

U.S. stocks saw a slight increase, with the Dow up 0.1%, S&P 500 up 0.24%, and NASDAQ gaining 0.17%. Energy shares rose by 1.8%, while communication services fell by 1.5%. Mosaic Co shares dropped 2% after missing Q1 earnings estimates. Functional Brands Inc surged 103% following an acquisition announcement, while Haoxi Health Technology Ltd plummeted 93% after a direct offering. Oil prices increased by 2%, and mixed performances were noted in European and Asian markets. U.S. existing home sales rose by 0.2% in April.

benzinga_article

Mosaic

Functional Brands

Dow Edges Higher; Mosaic Shares Fall After Q1 Results

YDKG

KNRX

In Friday's after-market session, several communication services stocks experienced notable movements. Gainers included TEN Hldgs (up 8.6% to $1.26), Yueda Digital Holding (up 2.98% to $0.89), and Knorex (up 2.94% to $1.05). Conversely, Global Mofy AI saw the largest decline, dropping 16.0% to $1.1, followed by Haoxi Health Technology (down 10.08% to $0.69) and K Wave Media (down 8.09% to $0.38).

Yueda Digital

Global Mofy AI

Knorex

K Wave Media

BUUU

Playstudios

Thryv

LZ Tech - B

Urban One

Playstudios - CW27

K WAVE MEDIA LTD C/WTS 14/05/2030(TO PUR COM)

12 Communication Services Stocks Moving In Friday's After-Market Session

LABU

Starcoin Group Limited has signed a memorandum of understanding with Huamei Haibo Biotechnology for strategic cooperation in equity investment, asset restructuring, and Web3.0 healthcare. The partnership aims to integrate Huamei Haibo’s cell-preparation systems and technologies, enhancing Starcoin's R&D and commercialization efforts in biotech. This collaboration is expected to create new revenue streams and strengthen Starcoin's position in the healthcare sector. The latest analyst rating for Innovative Pharmaceutical Biotech (HK:0399) is a Sell with a price target of HK$0.15.

Haoxi Health Tech(HAO.US)

Haoxi Health Announces 1-for-128 Reverse Share Split; Stock Plunges

Haoxi Health Technology Jumps Over 20%; What's The Buzz?

Dow Edges Higher; Mosaic Shares Fall After Q1 Results

12 Communication Services Stocks Moving In Friday's After-Market Session

Starcoin Group Signs Strategic Biotech Cooperation MOU With Huamei Haibo

Trending